ALIOF Stock UPDATES Actelion Ltd (ALIOF) 119.7000 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board

Aug 3, 2014 at 1:57 AM

Actelion Ltd (ALIOF) 119.7000 $ALIOF

Pharmacyclics Incurs Q2 Loss, Revenues Up on Imbruvica Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 01, 4:10PM CDT
Pharmacyclics (PCYC) reported better than expected revenues on strong Imbruvica sales.

Synageva Slips on Wider-than-Expected Q2 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 01, 3:30PM CDT
Synageva BioPharma Corp's second quarter 2014 loss came in at $1.52 per share, much wider than the year-ago loss of 81 cents per share and the Zacks Consensus Estimate of a loss of $1.37.

Endo International Beats on Q2 Earnings & Sales, Guidance Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 01, 2:36PM CDT
Endo (ENDP) reported higher-than-expected earnings and revenues in the quarter.

Incyte Posts Wider-than-Expected Q2 Loss, Raises Sales View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 01, 10:17AM CDT
Incyte Corporation (INCY) reported a loss of 22 cents per share in the second quarter of 2014, significantly wider than the Zacks Consensus Estimate of a loss of 9 cents.

United Therapeutics (UTHR) Up on Q2 Earnings & Revenue Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 12:20PM CDT
Lower costs and higher revenues helped United Therapeutics (UTHR) deliver better-than-expected earnings.

Ultragenyx Pharmaceutical (RARE) Jumps: Stock Rises 5.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 8:39AM CDT
Ultragenyx Pharmaceutical (RARE) was a big mover last session, as its shares rose over 5% on the day.

Sarepta Therapeutics (SRPT) Soars: Stock Rises 12.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 8:39AM CDT
Sarepta Therapeutics, Inc. (SRPT) was a big mover last session, as its shares rose nearly 13% on the day.

Strength Seen in Aegerion Pharmaceuticals (AEGR): Stock Shoots up 16.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 7:44AM CDT
Aegerion Pharmaceuticals, Inc. (AEGR) was a big mover last session, as the company saw its shares surge over 16% on the day.

Regeneron's Eylea Gets FDA Nod for Diabetic Macular Edema - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 6:00PM CDT
Regeneron Pharmaceuticals, Inc.'s (REGN) eye drug Eylea received FDA approval for a third indication: the treatment of diabetic macular edema.

Aegerion Q2 Loss Narrower than Expected, 2014 View Retained - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 2:15PM CDT
Aegerion (AEGR) reported second quarter 2014 net loss per share of 33 cents, narrower than the Zacks Consensus Estimate of a loss of 42 cents.

AMAG Pharmaceuticals Q2 Loss Narrows as Feraheme Sales Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 12:50PM CDT
AMAG's (AMAG) second quarter loss narrowed on the back of increased Feraheme sales.

Qiagen Reports In-line Earnings, Beats on Revenues in Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 12:20PM CDT
Qiagen N.V. (QGEN) reported second-quarter 2014 adjusted EPS of 25 cents.

Vertex Pharmaceuticals Posts Wider Q2 Loss, Maintains View - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jul 30, 12:10PM CDT
Vertex Pharma (VRTX) posted a wider second quarter loss and also missed revenue expectations.

Dynavax Technologies (DVAX) Jumps: Stock Gains 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 8:46AM CDT
Dynavax (DVAX) was a big mover last session, with shares rising over 6% on the day.

Amgen Beats on Q2 Earnings & Revs, Ups View & Plans Job Cuts - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jul 30, 8:20AM CDT
While Amgen's (AMGN) second quarter results were impressive, the company's restructuring plan remained in focus.

Synthetic Biologics Inc. (SYN) Looks Strong as Stock Gains 34.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 7:44AM CDT
Synthetic Biologics Inc. (SYN) was a big mover last session, as the company saw its shares rise nearly a massive 35% on the day.

Chronic Plaque Psoriasis - Pipeline Review, H1 2014
M2 - Wed Jul 30, 3:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dpkjk3/chronic_plaque) has announced the addition of the "Chronic Plaque Psoriasis - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Chronic Plaque Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Plaque Psoriasis and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Chronic Plaque Psoriasis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Chronic Plaque Psoriasis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Companies Mentioned: - AbGenomics International, Inc. - AbbVie Inc. - Actelion Ltd - Almirall, S.A. - ApoPharma Inc. - Biotest AG - Boehringer Ingelheim GmbH - Can-Fite BioPharma Ltd. - Eli Lilly and Company - GlaxoSmithKline plc - Incyte Corporation - Merck & Co., Inc. - Novartis AG - OPKO Health, Inc. - Pfizer Inc. - Sandoz Inc. For more information visit http://www.researchandmarkets.com/research/dp...nic_plaque

Heska (HSKA) Jumps: Stock Adds 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 8:25AM CDT
Heska (HSKA) was a big mover last session, with shares rising nearly 6% on the day.

Why AMAG Pharmaceuticals (AMAG) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 7:46AM CDT
AMAG Pharmaceuticals one such stock that can be considered to drop as it has witnessed a significant price decline and has seen negative earnings

Applied Genetic Technologies Corporation (AGTC) Looks Strong as Stock Surges 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 7:44AM CDT
Applied Genetic Technologies Corporation (AGTC) was a big mover last session, as the company saw its shares shoot up over 15% on the day.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FlyQuest & Von Dutch Link Gaming, Fashion Again

Breaking Down Barriers in Fashion and Gaming In a world full of unlikely matches, the partnership between FlyQuest and Von Dutch is one that's catching serious eyeballs. FlyQuest, an esports powerhouse, has teamed up once more with the iconic fashion brand Von Dutch to launch "The Workman Collection." This ain't just about slapping logos on t-shirts and calling it a...

ODL’s Impact Door System Wins 2026 Editors' Pick

Award-Winning Entry: ODL's Latest Triumph In a world where first impressions count, ODL, Inc. sure knows how to leave a mark. Their Impact Rated Fiberglass Entry System with Keystone Frame Technology snagged a notable spot in the 2026 Best of Products Awards by Architect's Newspaper. Let me tell you, in the building biz, accolades like these are no small potatoes. To get...

Morphe’s Auction Hits High Notes with Fine Jewelry

Luxurious Gems Steal the Spotlight When the gavel dropped at Morphy's Fine Jewelry & Watches Auction, it set the stage for a spectacular showcase of opulent treasures. The event, highlighting 632 lots and tallying over $1.8 million in sales, left bidders buzzing in anticipation of their next chance to snag a slice of elegance. Bvlgari's Serpentine Charm In the spotlight...

TKO's Bold $2B All-Cash Move for SVC's Hotels

TKO's Big, Bold Bid: What Does it Mean? In the crazy world of high-stakes hospitality investments, there are moments that turn heads. TKO's $2 billion all-cash offer to snag Service Properties Trust's prized hotel portfolio is exactly one of those shake-ups. Let's not sugarcoat it; this is a bold move to the big leagues, and it's not without its quirks. A Cash-Infused...

Chianti Classico Showcases 2027 Vintages in Florence

A Grand Reunion of the Black Rooster You're not just sipping wine at a garden party—you're diving into a historic event. Come March 1-2, 2027, Florence will again host the much-anticipated Chianti Classico Collection, uniting over 200 eager producers under the iconic vaults of Stazione Leopolda. This isn't just another stop on the wine circuit; it's a pilgrimage to the...

DIFF Eyewear Opens First Flagship Store in Charleston

DIFF Eyewear: From Clicks to Bricks in Charleston Here's a tale of a brand shaking things up, jumping from the digital stratosphere right into solid ground. DIFF Eyewear has officially planted its flag in Charleston, SC, marking a bold transition from being an exclusively online player to real-world retail. October 10th rang in their first brick-and-mortar store on...

Strategic Move: Chimney Collective Teams with Four Winds

A Partnership Fueled by Legacy and Growth In the world of brick, mortar, and flue, a big play just unfolded. Chimney Collective, flexing its investment muscle, has hitched its wagon to Four Winds Chimney, a company that's carved out quite a niche in New York's chimney scene. We're not talking about a corporate takeover here; this is about putting money where growth and...

Navigating Career Growth Beyond Job Titles at Webinar

Hasn't it ever struck you that job titles often fence people in like some unwanted corral, keeping potential tightly leashed? Well, here's something that might shake up your thoughts a tad. University of Phoenix is teeing up a webinar titled "Beyond The Job Title: Finding Purpose and Recognizing the Value You Bring." Scheduled for October 15, 2026, this is all about...

Ingram Mercantile's Aviation Push: SCORE or Sink?

Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...

Poker Fans Flock to Venom PKOs and WSOP Paradise

October's High Stakes Poker Action The poker buzz right now is centered around Americas Cardroom. With $5.5 million in guarantees across two major tournaments – the No-Limit Hold'em and Pot-Limit Omaha – players are reaching for their cash, hoping to lock in big wins. Day 1B kicks off today, offering a dynamic mix of players vying for their shot at glory while taking...